Literature DB >> 4758443

Editorial: Immunosuppressive therapy in active chronic hepatitis.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4758443      PMCID: PMC1587603          DOI: 10.1136/bmj.4.5890.441

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  10 in total

1.  Controlled trial of prednisone and azathioprine in active chronic hepatitis.

Authors:  I M Murray-Lyon; R B Stern; R Williams
Journal:  Lancet       Date:  1973-04-07       Impact factor: 79.321

2.  Cyclophosphamide and human organ transplantation.

Authors:  T E Starzl; C G Halgrimson; I Penn; G Martineau; G Schroter; H Amemiya; C W Putnam; C G Groth
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

3.  Prednisone side-effects and serum-protein levels. A collaborative study.

Authors:  G P Lewis; W J Jusko; L Graves; C W Burke
Journal:  Lancet       Date:  1971-10-09       Impact factor: 79.321

4.  Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.

Authors:  G C Cook; R Mulligan; S Sherlock
Journal:  Q J Med       Date:  1971-04

5.  Cell-mediated immune responses in chronic liver diseases.

Authors:  M G Smith; P L Golding; A L Eddleston; C G Mitchell; A Kemp; R Williams
Journal:  Br Med J       Date:  1972-02-26

6.  A human serum immunoglobulin with specificity for certain homologous target cells, which induces target cell damage by normal human lymphocytes.

Authors:  I C MacLennan; G Loewi; A Howard
Journal:  Immunology       Date:  1969-12       Impact factor: 7.397

7.  The treatment of active chronic hepatitis with 6-mercaptopurine and azathioprine.

Authors:  S P Mistilis; C R Blackburn
Journal:  Australas Ann Med       Date:  1967-11

8.  The dual necessity for delayed hypersensitivity and circulating antibody in the pathogenesis of experimental allergic orchitis in guinea-pigs.

Authors:  P C Brown; L E Glynn; E J Holborow
Journal:  Immunology       Date:  1967-09       Impact factor: 7.397

9.  Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis.

Authors:  J Miller; M G Smith; C G Mitchell; W D Reed; A L Eddleston; R Williams
Journal:  Lancet       Date:  1972-08-12       Impact factor: 79.321

10.  Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.

Authors:  L W Powell; E Axelsen
Journal:  Gut       Date:  1972-09       Impact factor: 23.059

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.